Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms.

Ovenden ES, Drögemöller BI, van der Merwe L, Chiliza B, Asmal L, Emsley RA, Warnich L.

Pharmacogenomics. 2017 Jan;18(2):105-120. doi: 10.2217/pgs-2016-0108. Epub 2016 Dec 19.

PMID:
27992301
2.

Replication of genome-wide association study (GWAS) susceptibility loci in a Latino bipolar disorder cohort.

Gonzalez S, Gupta J, Villa E, Mallawaarachchi I, Rodriguez M, Ramirez M, Zavala J, Armas R, Dassori A, Contreras J, Flores D, Jerez A, Ontiveros A, Nicolini H, Escamilla M.

Bipolar Disord. 2016 Sep;18(6):520-527. doi: 10.1111/bdi.12438.

3.

Genome-wide association study of treatment refractory schizophrenia in Han Chinese.

Liou YJ, Wang HH, Lee MT, Wang SC, Chiang HL, Chen CC, Lin CH, Chung MS, Kuo CC, Liao DL, Wu CK, Liu CM, Liu YL, Hwu HG, Lai IC, Tsai SJ, Chen CH, Liu HF, Chou YC, Chen CH, Chen YT, Hong CJ, Wu JY.

PLoS One. 2012;7(3):e33598. doi: 10.1371/journal.pone.0033598. Epub 2012 Mar 27.

4.

Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample.

Kendler KS, Kalsi G, Holmans PA, Sanders AR, Aggen SH, Dick DM, Aliev F, Shi J, Levinson DF, Gejman PV.

Alcohol Clin Exp Res. 2011 May;35(5):963-75. doi: 10.1111/j.1530-0277.2010.01427.x. Epub 2011 Feb 11.

Supplemental Content

Loading ...
Support Center